These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1509756)

  • 21. [False results of measuring digoxin levels in patients with renal failure. Comparison of the RIA--FPIA methods].
    Jankowski A; Karwowski J; Marzec A; Kretowicz W; Nartowicz E
    Kardiol Pol; 1990 Feb; 33(2):116-21. PubMed ID: 2277482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Criteria for identifying endogenous compounds as digoxin-like immunoreactive factors in humans.
    Lau BW; Valdes R
    Clin Chim Acta; 1988 Jun; 175(1):67-77. PubMed ID: 2844442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marked digoxin-like immunoreactive factor interference with an enzyme immunoassay.
    Karboski JA; Godley PJ; Frohna PA; Horton MW; Reitmeyer WJ
    Drug Intell Clin Pharm; 1988 Sep; 22(9):703-5. PubMed ID: 3063480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interference of endogenous digoxin-like immunoreactive factors in serum digoxin measurement is minimized in a new turbidimetric digoxin immunoassay on ADVIA 1650 analyzer.
    Datta P; Dasgupta A
    Ther Drug Monit; 2004 Feb; 26(1):85-9. PubMed ID: 14749555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excretion of endogenous digoxin-like immunoreactive factors in human urine is a function of urine flow rate.
    Siegfried BA; Valdes R
    Clin Chem; 1988 May; 34(5):960-4. PubMed ID: 3370798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deglycosylated products of endogenous digoxin-like immunoreactive factor in mammalian tissue.
    Qazzaz HM; Goudy SL; Valdes R
    J Biol Chem; 1996 Apr; 271(15):8731-7. PubMed ID: 8621507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations.
    Lackner TE; Lau BW; Parvin C; Valdes R
    Clin Pharm; 1988 Jun; 7(6):449-53. PubMed ID: 3402180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency].
    Li JH; Wu ZG; Xu JQ; Zhou Y
    Yao Xue Xue Bao; 1997; 32(3):174-7. PubMed ID: 11327016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Determination of endoxin in hypertensive patients].
    Gorjão Clara J; Breitenfeld B; Bicho M; Moreira C; Carvalho C; Boaventura I; Manso C; Nogueira da Costa J
    Rev Port Cardiol; 1991 Jan; 10(1):29-33. PubMed ID: 1647807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the carrier protein of digoxin-like immunoreactive substance in plasma.
    Montali U; Balzan S; Ghione S
    J Hypertens Suppl; 1987 Dec; 5(5):S299-302. PubMed ID: 3481818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous digoxin-like immunoreactive factor and digitalis-like factor associated with the hypertension of patients receiving multiple alkylating agents as part of autologous bone marrow transplantation.
    Graves SW; Eder JP; Schryber SM; Sharma K; Brena A; Antman KH; Peters WP
    Clin Sci (Lond); 1989 Nov; 77(5):501-7. PubMed ID: 2555106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and characterization of endogenous digoxin-like immunoreactive factors in chicken blood.
    Wei JS; Cheng HC; Tsai KJ; Liu DH; Lee HH; Chiu DT; Liu TZ
    Life Sci; 1996; 59(19):1617-29. PubMed ID: 8913327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic drug monitoring of digoxin: impact of endogenous and exogenous digoxin-like immunoreactive substances.
    Dasgupta A
    Toxicol Rev; 2006; 25(4):273-81. PubMed ID: 17288498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between umbilical artery and vein endogenous digoxin-like immuno-active factor levels in normal and pre-eclamptic patients.
    Schabort I; Odendaal HJ; Lombard CJ; Bredell L
    S Afr Med J; 1991 Feb; 79(4):197-9. PubMed ID: 1996437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups.
    Datta P; Xu L; Malik S; Landicho D; Ferreri L; Halverson K; Roby PV; Zebelman AM; Kenny MA
    Clin Chem; 1996 Mar; 42(3):373-9. PubMed ID: 8598098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Digoxin-like immunoreactive factor(s) in human gonadotropin stimulated follicular fluid.
    Jakobi P; Krivoy N; Eibschitz I; Ziskind G; Barzilai D; Paldi E
    J Clin Endocrinol Metab; 1989 Jul; 69(1):209-11. PubMed ID: 2499591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Endogenous digoxin-like factor: serum concentration and interrelations with the electrolyte picture in normal subjects].
    Andronico G; Mangano MT; Carone MB; Cerasola G
    Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1053-8. PubMed ID: 2560923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New enzyme-linked immunosorbent digoxin assay on the ADVIA IMS 800i system is virtually free from interference of endogenous digoxin-like immunoreactive factors.
    Dasgupta A; Kang E; Datta P
    Ther Drug Monit; 2005 Apr; 27(2):139-43. PubMed ID: 15795642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of human serum with sulfosalicylic acid structurally alters digoxin and endogenous digoxin-like immunoreactive factor.
    Qazzaz HM; Goudy S; Miller JJ; Valdes R
    Ther Drug Monit; 1995 Feb; 17(1):53-9. PubMed ID: 7725377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.